ZRO Stock Overview
Develops, manufactures, and sells chemical compounds for household and industrial applications in Canada.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
Biosenta Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.40 |
52 Week High | CA$0.89 |
52 Week Low | CA$0.15 |
Beta | 0.34 |
1 Month Change | -13.98% |
3 Month Change | -55.06% |
1 Year Change | 0% |
3 Year Change | 14.29% |
5 Year Change | n/a |
Change since IPO | 433.33% |
Recent News & Updates
Shareholder Returns
ZRO | CA Household Products | CA Market | |
---|---|---|---|
7D | 0% | -0.3% | -0.4% |
1Y | 0% | 10.8% | 11.4% |
Return vs Industry: ZRO underperformed the Canadian Household Products industry which returned 10.8% over the past year.
Return vs Market: ZRO underperformed the Canadian Market which returned 11.4% over the past year.
Price Volatility
ZRO volatility | |
---|---|
ZRO Average Weekly Movement | n/a |
Household Products Industry Average Movement | 3.2% |
Market Average Movement | 8.7% |
10% most volatile stocks in CA Market | 17.5% |
10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: ZRO's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine ZRO's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | Am Gill | www.biosenta.com |
Biosenta Inc. develops, manufactures, and sells chemical compounds for household and industrial applications in Canada. The company develops True, an anti-microbial, dual-action disinfectant for destroying viruses, bacteria, germs, molds, mildew, and fungi. It also manufactures and distributes Tri-Filler, an anti-microbial filler to perform filling and bulking functions.
Biosenta Inc. Fundamentals Summary
ZRO fundamental statistics | |
---|---|
Market cap | CA$12.70m |
Earnings (TTM) | -CA$6.53m |
Revenue (TTM) | CA$922.00 |
Over9,999x
P/S Ratio-1.9x
P/E RatioIs ZRO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ZRO income statement (TTM) | |
---|---|
Revenue | CA$922.00 |
Cost of Revenue | CA$4.04k |
Gross Profit | -CA$3.12k |
Other Expenses | CA$6.53m |
Earnings | -CA$6.53m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.21 |
Gross Margin | -338.61% |
Net Profit Margin | -708,139.91% |
Debt/Equity Ratio | -74.4% |
How did ZRO perform over the long term?
See historical performance and comparison